Interim analysis of a phase iii randomized, double-blind study of vorinostat or placebo combined with bortezomib in relapsed multple myeloma

• Authors: JAGANNATH S.; SIEGEL D.; HÁJEK Roman; DIMOPOULOS M.; YOON SS.; LONIAL S.; GRAEF T.; LUPINACCI L.; REISER D.; ANDERSON K.
• Year of publication: 2010
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: This is a large international randomized trial that has passed the initial safety evaluations by DMC and is accruing patients rapidly all over the world. Updated safety data and enrollment status from the second DMC meeting held in April 2010 will be presented.